Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. AptarGroup, Inc.
  6. Summary
    ATR   US0383361039

APTARGROUP, INC.

(ATR)
  Report
Delayed Nyse  -  04:00 2022-07-06 pm EDT
102.64 USD   -0.27%
06/22Aptar Releases 2021 Corporate Sustainability / ESG Report
BU
06/08Opiant Pharmaceuticals, Inc. announced that it expects to receive $2.1 million in funding from AptarGroup, Inc., Valois SAS
CI
06/07INSIDER SELL : Aptargroup
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/29/2022 06/30/2022 07/01/2022 07/05/2022 07/06/2022 Date
103.39(c) 103.21(c) 104.49(c) 102.92(c) 102.64(c) Last
220 930 205 874 262 328 230 164 286 394 Volume
+0.67% -0.17% +1.24% -1.50% -0.27% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 3 389 M - -
Net income 2022 261 M - -
Net Debt 2022 1 077 M - -
P/E ratio 2022 26,3x
Yield 2022 1,51%
Sales 2023 3 554 M - -
Net income 2023 298 M - -
Net Debt 2023 958 M - -
P/E ratio 2023 22,9x
Yield 2023 1,59%
Capitalization 6 730 M 6 730 M -
EV / Sales 2022 2,30x
EV / Sales 2023 2,16x
Nbr of Employees 13 000
Free-Float 92,5%
More Financials
Company
AptarGroup, Inc. is a designer and manufacturer of a range of drug delivery and consumer product dispensing, sealing and active packaging solutions and services. The Company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment includes operations that sell dispensing systems, drug delivery systems, sealing solutions and services to the prescription drug, consumer health... 
Read more
More about the company
Ratings of AptarGroup, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about APTARGROUP, INC.
06/22Aptar Releases 2021 Corporate Sustainability / ESG Report
BU
06/08Opiant Pharmaceuticals, Inc. announced that it expects to receive $2.1 million in fundi..
CI
06/07INSIDER SELL : Aptargroup
MT
05/18Aptar Named Among the 100 Best Corporate Citizens for 2022
BU
05/05APTARGROUP, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/02Wells Fargo Adjusts AptarGroup Price Target to $150 From $156, Maintains Overweight Rat..
MT
04/29APTARGROUP, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
04/29Tranche Update on AptarGroup, Inc.'s Equity Buyback Plan announced on April 18, 2019.
CI
04/29TRANSCRIPT : AptarGroup, Inc., Q1 2022 Earnings Call, Apr 29, 2022
CI
04/28APTARGROUP : Aptar Reports First Quarter 2022 Results - Form 8-K
PU
04/28APTARGROUP : Q1 Press Release Presentation
PU
04/28APTARGROUP : 2022 Reconciliation of Non-GAAP Financial Measures
PU
04/28AptarGroup Q1 EPS Meets, Revenue Tops Street View; Sets Q2 Earnings Outlook
MT
04/28APTARGROUP : Q1 Earnings Snapshot
AQ
04/28Aptar Reports First Quarter 2022 Results
BU
More news
News in other languages on APTARGROUP, INC.
06/07VENTE D'INITIÉS : Aptargroup
04/28Le bénéfice par action d'AptarGroup pour le premier trimestre est conforme aux attentes..
04/28Earnings Flash (ATR) APTARGROUP annonce un chiffre d'affaires de 844,9 millions de doll..
04/28AptarGroup, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2022
04/14Aptargroup, Inc. Déclare un dividende trimestriel, la date de paiement est le 18 mai 20..
More news
Analyst Recommendations on APTARGROUP, INC.
More recommendations
Chart APTARGROUP, INC.
Duration : Period :
AptarGroup, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends APTARGROUP, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 102,64 $
Average target price 139,00 $
Spread / Average Target 35,4%
EPS Revisions
Managers and Directors
Stephan B. Tanda President, Chief Executive Officer & Director
Robert W. Kuhn Chief Financial Officer & Executive Vice President
George L. Fotiades Non-Executive Chairman
Ralf Klaus Wunderlich Independent Non-Executive Director
Giovanna Kampouri Monnas Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
APTARGROUP, INC.-15.97%6 730
BERRY GLOBAL GROUP, INC.-26.23%7 103
FP CORPORATION-28.21%1 696
SHENZHEN LEAGUER CO., LTD.-18.78%1 652
SHANGHAI ZIJIANG ENTERPRISE GROUP CO., LTD.-31.05%1 456
SCIENTEX BERHAD-26.93%1 238